MoonLake Immunotherapeuti... (MLTX)
NASDAQ: MLTX
· Real-Time Price · USD
53.87
-1.01 (-1.84%)
At close: Aug 15, 2025, 3:04 PM
MoonLake Immunotherapeutics Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for MLTX stock have an median target of 70, with a low estimate of 61 and a high estimate of 100. The median target predicts an increase of 29.94% from the current stock price of 53.87.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 61 | 74.83 | 70 | 100 |
| Change | 13.24% | 38.91% | 29.94% | 85.63% |
Latest Analyst Insight Report
RBC Capital maintains an Outperform rating on Moon... Unlock content with Pro Subscription
Updated Jun 03, 2025
| Rating | Feb 25 | Mar 25 | Apr 25 | May 25 | Jun 25 | Aug 25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 0 | 0 | 0 | 1 |
| Buy | 2 | 1 | 1 | 2 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 1 | 1 | 2 | 1 | 1 |
Financial Forecast this Year
Revenue This Year
n/a
Revenue Next Year
0
from 0
Increased by n/a%
EPS This Year
-3.26
from -1.89
Increased by -72.5%
EPS Next Year
-4
from -3.26
Increased by -22.7%